EJNMMI Radiopharmacy and Chemistry

Show Articles
Journal Properties
  • Country
    Switzerland
  • Language
    English
  • Number of Articles
    251
  • Abbreviation
    EJNMMI Radiopharm Chem
  • e-ISSN
    2365-421X
  • Main Publisher
    Springer Nature
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • DOAJ (latest)
Journal Properties
  • Final Decision (day)
    35
  • Medicine
    Medicine (General)
    Medical physics
    Medical radiology
    Nuclear medicine
    Medicine
    Therapeutics
    Pharmacology
    Science
    Chemistry
    Inorganic chemistry
  • website
Description
EJNMMI Radiopharmacy and Chemistry is a specialized journal focused on the innovative science of radiopharmaceuticals and their applications in medical imaging. It covers the entire lifecycle of these crucial compounds, from synthesis and preclinical evaluation to clinical translation and quality control. This journal publishes research on the design, development, and production of radiopharmaceuticals, as well as their use in positron emission tomography (PET), single-photon emission computed tomography (SPECT), and other imaging modalities. Indexed in key databases like Scopus and PubMed, EJNMMI Radiopharmacy and Chemistry serves as a key resource for radiochemists, nuclear medicine physicians, and researchers in related fields. By fostering collaboration and knowledge-sharing, this journal plays a vital role in advancing the development of novel radiopharmaceuticals and improving diagnostic accuracy in medicine. Consider submitting your research to contribute to this cutting-edge field. It is open access.
Directory of Open Access Journals (DOAJ)
There is further information about this journal. Please follow links.